Asensus Surgical, Inc. (ASXC)

Asensus Surgical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-78.71	-78.43	-75.56	-62.46	-60.02	-154.2
Depreciation & Amortization	3.76	3.73	11.08	14.11	13.7	12.47
Share-Based Compensation	7.75	7.92	8.42	9.43	7.91	11.51
Other Operating Activities	6.82	3.16	-2.87	-1.74	-8.97	56.74
Operating Cash Flow	-60.39	-63.63	-58.94	-40.66	-46.68	-73.48
Capital Expenditures	-0.5	-0.56	-1.28	-1.37	-0	15.53
Change in Investments	38.27	65.07	48.82	-118.3	0	52.12
Investing Cash Flow	37.77	64.51	47.54	-119.67	-0	67.65
Share Issuance / Repurchase	11.1	10.12	0.02	162.77	50.67	26.32
Debt Issued / Paid	0	0	0	0	2.82	-31.43
Other Financing Activities	-0.18	-0.5	-0.35	-1.06	-0.11	-0.5
Financing Cash Flow	10.92	9.63	-0.33	161.71	53.37	-5.61
Exchange Rate Effect	0.3	0.76	-0.08	0.38	0.27	0.36
Net Cash Flow	-11.4	11.27	-11.81	1.75	6.96	-11.08
Free Cash Flow	-60.88	-64.19	-60.22	-42.03	-46.68	-57.96
Free Cash Flow Margin	-697.89%	-748.37%	-849.67%	-510.53%	-1470.17%	-679.36%
Free Cash Flow Per Share	-0.23	-0.26	-0.26	-0.18	-0.66	-3.27

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).